HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, Z. Articles by Yu, J. Search for Related Content PubMed PubMed Citation Articles by Xia, Z. Articles by Yu, J. Related Collections Myocardial protection

J Thorac Cardiovasc Surg 2003;126:1404-1410
© 2003 The American Association for Thoracic Surgery

Surgery for congenital heart disease

Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease

^a Department of Anesthesiology, Affiliated Renmin Hospital, Wuhan University, Wuhan, PR China
^b Centre for Anesthesia and Analgesia, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Received for publication September 6, 2002; revisions received October 16, 2002; revisions received January 2, 2003; accepted for publication March 25, 2003.

^* Address for reprints: Zhengyuan Xia, MD, Centre for Anesthesia and Analgesia, Department of Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
xia{at}neuro.pharmacology.ubc.ca

OBJECTIVE: The endothelium-derived vasoconstrictor endothelin-1 is increased after cardiopulmonary bypass in children with congenital heart defects. This study determines whether antioxidant therapy with Salvia miltiorrhiza injection, an herb extract containing phenolic compounds, prevents the postoperative increase of endothelin-1. The relationship between endothelin-1 and the endothelium-derived prostacyclin (prostaglandin I2) and thromboxane A2 postoperatively is also investigated.

METHODS: Twenty children with congenital heart defects and pulmonary hypertension were randomly assigned to group A (placebo control, n=10) or B (200 mg/kg Salvia miltiorrhiza intravenously after anesthesia induction and at the time of rewarming, respectively; n =10) before cardiac surgery. Central venous blood samples were taken before operation (T₀), 10 (T₁) and 30 minutes (T₂) after starting cardiopulmonary bypass, 10 (T₃) and 30 minutes (T₄) after aortic declamping, and 30 minutes (T₅) and 24 hours (T₆) after termination of cardiopulmonary bypass. Plasma lipid peroxidation product malondialdehyde, myocardial specific creatine kinase-MB activity, thromboxane B2, and 6-keto-prostaglandin F₁ (stable metabolites of thromboxane A2 and prostaglandin I2) were measured.

RESULTS: Malondialdehyde increased significantly at T₁ in group A and remained significantly higher than in group B thereafter (P < .05). Malondialdehyde in group B did not significantly increase over time. At T₅, plasma creatine kinase-MB, thromboxane B2, and endothelin-1 in group B were lower than in group A (P < .05); malondialdehyde correlated significantly with creatine kinase-MB (r = 0.71, P = .0005). At T₆, endothelin-1 negatively correlated with the 6-keto-prostaglandin F₁/thromboxane B2 ratio (r = -0.64, P = .0025).

CONCLUSION: Antioxidant therapy reduces myocardial damage and attenuates postoperative vasoactive mediator imbalance.

This article has been cited by other articles:

				Z. Xia, Z. Huang, and D. M. Ansley Large-Dose Propofol During Cardiopulmonary Bypass Decreases Biochemical Markers of Myocardial Injury in Coronary Surgery Patients: A Comparison with Isoflurane. Anesth. Analg., September 1, 2006; 103(3): 527 - 532. [Abstract] [Full Text] [PDF]

				T. Luo and Z. Xia A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in inducing human vascular endothelial cell apoptosis: reversal with propofol. Anesth. Analg., July 1, 2006; 103(1): 110 - 116. [Abstract] [Full Text] [PDF]

				Z. Xia, K.-H. Kuo, D. V. Godin, M. J. Walker, M. C. Y. Tao, and D. M. Ansley 15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1366 - H1372. [Abstract] [Full Text] [PDF]

				Z.-y. Xia, X.-Y. Liu, L.-y. Zhan, Y.-h. He, T. Luo, and Z. Xia Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 258 - 264. [Abstract] [Full Text] [PDF]

				Z. Xia, R. Xia, H.-T. Lan, T. Luo, Q.-Z. Tang, Z.-Y. Xia, and X.-Y. Liu Systemic ischemic preconditioning plus hemodilution enhanced early functional recovery of reperfused heart in the rabbits Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 528 - 532. [Abstract] [Full Text] [PDF]